Back to today’s briefing

Story perspectives

Study Reveals TCF7 Gene Cuts Midlife Mortality by 69%

4/25/2025

40 3

Summary

Story summary

A groundbreaking study of over 17,000 people reveals that immune resilience is vital for a long, healthy life. The TCF7 gene plays a key role, slashing midlife mortality risk by an impressive 69%. Strengthening immune health during midlife can combat aging, but after 70, mortality rates level off, suggesting natural limits to lifespan.

1 of 1

Story summary

A groundbreaking study of over 17,000 people reveals that immune resilience is vital for a long, healthy life. The TCF7 gene plays a key role, slashing midlife mortality risk by an impressive 69%. Strengthening immune health during midlife can combat aging, but after 70, mortality rates level off, suggesting natural limits to lifespan.